Related Experiment Video
Updated: Jun 17, 2025

Analysis of Raw and Processed Cyperi Rhizoma Samples Using Liquid Chromatography-Tandem Mass Spectrometry in Rats with Primary Dysmenorrhea
Published on: December 23, 2022
Oleanane-type triterpenoids from Sabia limoniacea and their anti-inflammatory activities
Yan Huang1, Ping Hou2, Li-Wei Pan2
1State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovation Center for Guangxi Ethnic Medicine, School of Chemistry and Pharmaceutical Sciences, Guangxi Normal University, Guilin 541004, China; Guangxi Key Laboratory of Traditional Chinese Medicine Quality Standards, Guangxi Institute of Chinese Medicine & Pharmaceutical Science, Nanning 530022, China.
Eighteen new oleanane-type triterpenoids were isolated from Sabia limoniacea. Several compounds, including sabialimon P, demonstrated significant anti-inflammatory activity by inhibiting nitric oxide and other key inflammatory markers.
Area of Science:
- Natural Products Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Sabia limoniacea is a plant source of bioactive compounds.
- Triterpenoids are a diverse class of natural products with various biological activities.
- Understanding the chemical diversity and bioactivity of plant-derived compounds is crucial for drug discovery.
Purpose of the Study:
- To isolate and characterize new oleanane-type triterpenoids from Sabia limoniacea.
- To elucidate the unprecedented pentacyclic skeleton of sabialimon A.
- To evaluate the anti-inflammatory potential of the isolated compounds.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation through extensive spectroscopic analyses (1D/2D NMR, HRESIMS).
- X-ray crystallographic studies and electronic circular dichroism measurements for structural confirmation.
- In vitro biological assays to assess inhibitory activity against nitric oxide (NO) release and inflammatory markers in LPS-induced RAW264.7 cells.
Main Results:
- Eighteen new oleanane-type triterpenoids, including sabialimon A with a unique 6/6/6/7/7 pentacyclic skeleton, were isolated.
- Sabialimon I, K, P, and compound 20 showed significant inhibition of nitric oxide release.
- Sabialimon P demonstrated dose-dependent inhibition of TNF-α, iNOS, IL-6, NF-κB secretion, and COX-2, NF-κB/p65 expression.
Conclusions:
- The study successfully identified novel triterpenoids with a rare pentacyclic structure from Sabia limoniacea.
- Specific isolated compounds, particularly sabialimon P, exhibit potent anti-inflammatory properties.
- These findings highlight the potential of Sabia limoniacea-derived triterpenoids as therapeutic agents for inflammatory conditions.
Related Concept Videos
Drugs for Treatment of Ulcerative Colitis in IBD
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Drugs for Treatment of Constipation-Predominant IBS
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...

